Patent details

Basic Information

Publication number:

EP1778723

PCT Application Number:

PCT/US/2005/029428

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057892523

PCT Publication Number:

WO/2006/023665

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IL-1 ANTAGONIST FORMULATIONS

French Title of Invention:

FORMULATIONS D'UN ANTAGONISTE IL-1

German Title of Invention:

IL-1-ANTAGONISTENFORMULIERUNGEN

SPC Number:

Dates

Filing date:

17/08/2005

Grant date:

14/11/2012

EP Publication Date:

14/11/2012

PCT Publication Date:

02/03/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/05/2007

EP B1 Publication Date:

14/11/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/08/2022

Expiration date:

17/08/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/08/2005

 

 

Name:

REGENERON PHARMACEUTICALS, INC.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

21/11/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHIMANLALL Goolcharran

Address:

United States (US)

2

Name:

BOWERS Katherine

Address:

United States (US)

3

Name:

DIX Daniel

Address:

United States (US)

Priority

Priority Number:

602137 P

Priority Date:

17/08/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/17;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

29/07/2021

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages